Evidence map›Paper›PMID 28176885›Full record

ArticleScientific reports2017

A novel human artery model to assess the magnetic accumulation of SPIONs under flow conditions.

Agata Janikowska, Jasmin Matuszak, Stefan Lyer, Eveline Schreiber, Harald Unterweger, Jan Zaloga, Jürgen Groll, Christoph Alexiou, Iwona Cicha

Abstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Effect of clinically relevant iron oxide nanoparticles on macrophage polarization, tumor growth and tumor microenvironment modulation.Journal of controlled release : official journal of the Controlled Release Society · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Agata JanikowskaSection of Experimental Oncology und Nanomedicine (SEON), ENT-Department, University Hospital Erlangen, Erlangen, Germany.
Jasmin MatuszakSection of Experimental Oncology und Nanomedicine (SEON), ENT-Department, University Hospital Erlangen, Erlangen, Germany.
Stefan LyerSection of Experimental Oncology und Nanomedicine (SEON), ENT-Department, University Hospital Erlangen, Erlangen, Germany.
Eveline SchreiberSection of Experimental Oncology und Nanomedicine (SEON), ENT-Department, University Hospital Erlangen, Erlangen, Germany.
Harald UnterwegerSection of Experimental Oncology und Nanomedicine (SEON), ENT-Department, University Hospital Erlangen, Erlangen, Germany.
Jan ZalogaSection of Experimental Oncology und Nanomedicine (SEON), ENT-Department, University Hospital Erlangen, Erlangen, Germany.
Jürgen GrollDepartment of Functional Materials in Medicine and Dentistry, University Hospital Würzburg, Würzburg, Germany.
Christoph AlexiouSection of Experimental Oncology und Nanomedicine (SEON), ENT-Department, University Hospital Erlangen, Erlangen, Germany.
Iwona CichaSection of Experimental Oncology und Nanomedicine (SEON), ENT-Department, University Hospital Erlangen, Erlangen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Magnetic targeting utilises the properties of superparamagnetic iron oxide nanoparticles (SPIONs) to accumulate particles in specified vasculature regions under an external magnetic field. As the behaviour of circulating particles varies depending on nanoparticle characteristics, magnetic field strength and flow dynamics, we established an improved ex vivo model in order to estimate the magnetic capture of SPIONs in physiological-like settings. We describe here a new, easy to handle ex vivo model of human umbilical artery. Using this model, the magnetic targeting of different types of SPIONs under various external magnetic field gradients and flow conditions was investigated by atomic emission spectroscopy and histology. Among tested particles, SPION-1 with lauric acid shell had the largest capacity to accumulate at the specific artery segment. SPION-2 (lauric acid/albumin-coated) were also successfully targeted, although the observed peak in the iron content under the tip of the magnet was smaller than for SPION-1. In contrast, we did not achieve magnetic accumulation of dextran-coated SPION-3. Taken together, the umbilical artery model constitutes a time- and cost-efficient, 3R-compliant tool to assess magnetic targeting of SPIONs under flow. Our results further imply the possibility of an efficient in vivo targeting of certain types of SPIONs to superficial arteries.

Indexed as

Models, BiologicalRheologyHumansMagnetite NanoparticlesTime FactorsUmbilical ArteriesMagnetite Nanoparticles

Identifiers

PMID28176885
PMCPMC5296745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.